Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025)
Rockwell Medical's (RMTI) quarterly Total Non-Current Liabilities came in at $20.2 million in Q4 2025, down 21.3% on a YoY basis from $25.6 million in Q4 2024, and down 1.48% quarter-over-quarter from $20.5 million in Q3 2025.
Analysis
Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends
Rockwell Medical (RMTI) has reported Total Non-Current Liabilities for 11 consecutive years, with $20.2 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities fell 21.3% year-over-year to $20.2 million; the trailing twelve-month figure through Dec 2025 stood at $20.2 million (down 21.3% YoY), and the FY2025 full-year result was $20.2 million, down 21.3% from the prior year.
- Total Non-Current Liabilities declined to $20.2 million in Q4 2025 per RMTI's latest filing, from $20.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $46.0 million in Q4 2021 and bottomed at $19.5 million in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $29.4 million across 5 years, with a median of $27.9 million in 2023.
- The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities climbed 5.62% in 2021, then slumped 33.89% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $46.0 million in 2021, then declined by 29.35% to $32.5 million in 2022, then decreased by 12.71% to $28.4 million in 2023, then dropped by 9.72% to $25.6 million in 2024, then slipped by 21.3% to $20.2 million in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $20.2 million, $20.5 million, and $22.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 23.92 Bn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 17.56 Bn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 996.30 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 12.41 Bn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | -89.27 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 75.19 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 13.70 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | 4.54 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | 333,758.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 20.16 Mn |
| Sep 30, 2025 | 20.47 Mn |
| Jun 30, 2025 | 22.22 Mn |
| Mar 31, 2025 | 19.54 Mn |
| Dec 31, 2024 | 25.62 Mn |
| Sep 30, 2024 | 26.20 Mn |
| Jun 30, 2024 | 27.03 Mn |
| Mar 31, 2024 | 27.58 Mn |
| Dec 31, 2023 | 28.38 Mn |
| Sep 30, 2023 | 28.59 Mn |
| Jun 30, 2023 | 28.50 Mn |
| Mar 31, 2023 | 27.92 Mn |
| Dec 31, 2022 | 32.52 Mn |
| Sep 30, 2022 | 38.04 Mn |
| Jun 30, 2022 | 38.96 Mn |
| Mar 31, 2022 | 42.23 Mn |
| Dec 31, 2021 | 46.03 Mn |
| Dec 31, 2020 | 43.58 Mn |
| Sep 30, 2014 | 25.11 Mn |
| Jun 30, 2014 | 25.57 Mn |